Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Ready to talk to a Rivas physician
This opens treatment to millions of seniors
We will collaborate closely with you to track your development, talk about any possible drug interactions, and modify your treatment plan as needed
Have appropriate emergency medications available, particularly if you have known allergies
A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)
Now, my workouts feel more rewarding and purposeful than ever before
US$ 23.28
US$ 25.34
US$ 20.17
US$ 22.65
US$ 26.47
US$ 28.75
US$ 23.94
US$ 24.99
US$ 25.07
